ADC Therapeutics SA Peo Total Comp Amt
ADC Therapeutics SA (ADCT) reported Peo Total Comp Amt of $2.45 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-20.
Financial Statements › Notes
ecd:PeoTotalCompAmt · last filed 2026-04-20
| Period end | Peo Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $2.45M DEF 14A · filed 2026-04-20 |
| 2024-12-31 | $1.84M DEF 14A · filed 2026-04-20 |
| 2023-12-31 | $3.78M DEF 14A · filed 2026-04-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |